2011-2021年中国青少年复发性呼吸道乳头状瘤病的特征:一项以医院为基础的全国性研究

IF 4.8 2区 医学 Q1 INFECTIOUS DISEASES
Changchang Dun, Yutong Li, Wenbin Lei, Yun Li, Hui Yang, Yalikun Yasen, Nilipaer Alimu, Dapeng Lei, Dongyan Chen, Qingquan Hua, Zhen Xu, Zhe Zhang, Guangke Wang, Weiwei Wang, Li Shi, Xin Wang, Xuelian Zhao, Shangying Hu, Xiaoguang Ni, Jie Zhang, Jun Wang, Fanghui Zhao
{"title":"2011-2021年中国青少年复发性呼吸道乳头状瘤病的特征:一项以医院为基础的全国性研究","authors":"Changchang Dun, Yutong Li, Wenbin Lei, Yun Li, Hui Yang, Yalikun Yasen, Nilipaer Alimu, Dapeng Lei, Dongyan Chen, Qingquan Hua, Zhen Xu, Zhe Zhang, Guangke Wang, Weiwei Wang, Li Shi, Xin Wang, Xuelian Zhao, Shangying Hu, Xiaoguang Ni, Jie Zhang, Jun Wang, Fanghui Zhao","doi":"10.1016/j.ijid.2025.107972","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To assess the demographic and clinical characteristics, treatment and health outcome, and economic burden of JoRRP in China.</p><p><strong>Methods: </strong>We identified twelve hospitals mainly responsible for JoRRP management across China to enroll patients presenting for JoRRP between Jan 1, 2011, and Dec 31, 2021. Data were primarily extracted from medical records, and missing values were additionally collected through telephone or outpatient interviews by two researchers independently. We used counts (proportions) and median values (interquartile range, IQR) to describe data. We applied the Lorenz curve and the concentration index (C-index) to indicate the wealth-related and education-related inequalities in JoRRP.</p><p><strong>Results: </strong>Of the 361 enrolled JoRRP patients, the median age at first diagnosis was 2.7 years (IQR: 1.5-5.0). During the 7.2-year median follow-up, we observed that 314 (87.0%) patients experienced relapse and 125 (38.0%) patients underwent aggressive clinical course. The median value for the estimated total economic costs per patient was 8717.5$ (IQR: 4700.6$-15359.1$) and the occurrence of catastrophic health expenditure was concentrated in families with low incomes and less-educated parents.</p><p><strong>Conclusions: </strong>Chinese JoRRP patients experienced significant disease burden characterized by severe clinical symptoms and substantial economic costs. Strategic healthcare plans for JoRRP are needed for disease mitigation in China.</p>","PeriodicalId":14006,"journal":{"name":"International Journal of Infectious Diseases","volume":" ","pages":"107972"},"PeriodicalIF":4.8000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Characteristics of juvenile-onset recurrent respiratory papillomatosis in China, 2011-2021: a hospital-based nationwide study.\",\"authors\":\"Changchang Dun, Yutong Li, Wenbin Lei, Yun Li, Hui Yang, Yalikun Yasen, Nilipaer Alimu, Dapeng Lei, Dongyan Chen, Qingquan Hua, Zhen Xu, Zhe Zhang, Guangke Wang, Weiwei Wang, Li Shi, Xin Wang, Xuelian Zhao, Shangying Hu, Xiaoguang Ni, Jie Zhang, Jun Wang, Fanghui Zhao\",\"doi\":\"10.1016/j.ijid.2025.107972\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>To assess the demographic and clinical characteristics, treatment and health outcome, and economic burden of JoRRP in China.</p><p><strong>Methods: </strong>We identified twelve hospitals mainly responsible for JoRRP management across China to enroll patients presenting for JoRRP between Jan 1, 2011, and Dec 31, 2021. Data were primarily extracted from medical records, and missing values were additionally collected through telephone or outpatient interviews by two researchers independently. We used counts (proportions) and median values (interquartile range, IQR) to describe data. We applied the Lorenz curve and the concentration index (C-index) to indicate the wealth-related and education-related inequalities in JoRRP.</p><p><strong>Results: </strong>Of the 361 enrolled JoRRP patients, the median age at first diagnosis was 2.7 years (IQR: 1.5-5.0). During the 7.2-year median follow-up, we observed that 314 (87.0%) patients experienced relapse and 125 (38.0%) patients underwent aggressive clinical course. The median value for the estimated total economic costs per patient was 8717.5$ (IQR: 4700.6$-15359.1$) and the occurrence of catastrophic health expenditure was concentrated in families with low incomes and less-educated parents.</p><p><strong>Conclusions: </strong>Chinese JoRRP patients experienced significant disease burden characterized by severe clinical symptoms and substantial economic costs. Strategic healthcare plans for JoRRP are needed for disease mitigation in China.</p>\",\"PeriodicalId\":14006,\"journal\":{\"name\":\"International Journal of Infectious Diseases\",\"volume\":\" \",\"pages\":\"107972\"},\"PeriodicalIF\":4.8000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ijid.2025.107972\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ijid.2025.107972","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

目的:评估中国JoRRP的人口学和临床特征、治疗和健康结局以及经济负担。方法:我们在中国选取了12家主要负责JoRRP管理的医院,纳入2011年1月1日至2021年12月31日期间进行JoRRP治疗的患者。数据主要从医疗记录中提取,另外由两位研究人员独立通过电话或门诊访谈收集缺失值。我们使用计数(比例)和中位数(四分位间距,IQR)来描述数据。我们应用Lorenz曲线和集中度指数(C-index)来表示JoRRP中与财富相关和与教育相关的不平等。结果:在361例纳入的JoRRP患者中,首次诊断时的中位年龄为2.7岁(IQR: 1.5-5.0)。在中位随访7.2年期间,我们观察到314例(87.0%)患者复发,125例(38.0%)患者出现侵袭性临床病程。每位患者估计总经济成本的中位数为8717.5美元(IQR: 4700.6 -15359.1美元),灾难性卫生支出的发生集中在低收入和父母受教育程度较低的家庭。结论:中国JoRRP患者存在显著的疾病负担,其特点是临床症状严重,经济成本高。中国需要针对JoRRP的战略性医疗保健计划来缓解疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Characteristics of juvenile-onset recurrent respiratory papillomatosis in China, 2011-2021: a hospital-based nationwide study.

Objectives: To assess the demographic and clinical characteristics, treatment and health outcome, and economic burden of JoRRP in China.

Methods: We identified twelve hospitals mainly responsible for JoRRP management across China to enroll patients presenting for JoRRP between Jan 1, 2011, and Dec 31, 2021. Data were primarily extracted from medical records, and missing values were additionally collected through telephone or outpatient interviews by two researchers independently. We used counts (proportions) and median values (interquartile range, IQR) to describe data. We applied the Lorenz curve and the concentration index (C-index) to indicate the wealth-related and education-related inequalities in JoRRP.

Results: Of the 361 enrolled JoRRP patients, the median age at first diagnosis was 2.7 years (IQR: 1.5-5.0). During the 7.2-year median follow-up, we observed that 314 (87.0%) patients experienced relapse and 125 (38.0%) patients underwent aggressive clinical course. The median value for the estimated total economic costs per patient was 8717.5$ (IQR: 4700.6$-15359.1$) and the occurrence of catastrophic health expenditure was concentrated in families with low incomes and less-educated parents.

Conclusions: Chinese JoRRP patients experienced significant disease burden characterized by severe clinical symptoms and substantial economic costs. Strategic healthcare plans for JoRRP are needed for disease mitigation in China.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
18.90
自引率
2.40%
发文量
1020
审稿时长
30 days
期刊介绍: International Journal of Infectious Diseases (IJID) Publisher: International Society for Infectious Diseases Publication Frequency: Monthly Type: Peer-reviewed, Open Access Scope: Publishes original clinical and laboratory-based research. Reports clinical trials, reviews, and some case reports. Focuses on epidemiology, clinical diagnosis, treatment, and control of infectious diseases. Emphasizes diseases common in under-resourced countries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信